ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,018.62
0.12%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Biofrontera Inc (BFRI)

  7. Biofrontera Inc (BFRI) Noticias

BFRI

Biofrontera (BFRI)

Biofrontera Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BFRI
FechaHoraFuenteTítuloSímboloCompañía
08/03/202416:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BFRIBiofrontera Inc
05/03/202416:20Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BFRIBiofrontera Inc
23/02/202408:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIBiofrontera Inc
20/02/202406:55Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BFRIBiofrontera Inc
09/01/202416:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BFRIBiofrontera Inc
17/11/202305:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BFRIBiofrontera Inc
09/11/202316:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BFRIBiofrontera Inc
01/11/202316:09Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BFRIBiofrontera Inc
30/10/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIBiofrontera Inc
04/10/202320:48Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BFRIBiofrontera Inc
22/08/202315:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BFRIBiofrontera Inc
20/06/202315:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BFRIBiofrontera Inc
28/04/202308:12Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:BFRIBiofrontera Inc
11/04/202315:44Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BFRIBiofrontera Inc
16/12/202207:30GlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIBiofrontera Inc
08/12/202215:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BFRIBiofrontera Inc
30/11/202213:08GlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIBiofrontera Inc
28/11/202210:05GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIBiofrontera Inc
21/11/202207:48GlobeNewswire Inc.Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkNASDAQ:BFRIBiofrontera Inc
15/11/202216:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BFRIBiofrontera Inc
14/11/202207:59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BFRIBiofrontera Inc
14/11/202207:45GlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIBiofrontera Inc
14/11/202205:05Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:BFRIBiofrontera Inc
10/11/202210:52GlobeNewswire Inc.Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022NASDAQ:BFRIBiofrontera Inc
08/11/202215:45GlobeNewswire Inc.Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGNASDAQ:BFRIBiofrontera Inc
08/11/202205:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BFRIBiofrontera Inc
04/11/202215:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BFRIBiofrontera Inc
03/11/202205:06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BFRIBiofrontera Inc
31/10/202207:55GlobeNewswire Inc.Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGNASDAQ:BFRIBiofrontera Inc
24/10/202206:45GlobeNewswire Inc.Biofrontera Inc. Names Fred Leffler as Chief Financial OfficerNASDAQ:BFRIBiofrontera Inc
 Showing the most relevant articles for your search:NASDAQ:BFRI

Su Consulta Reciente

NYSE
AFSS
LSE
0F5V
M&c
TSXV
ENTG.DB
Entourage Health
LSE
USSC
Spdr Usa Sc Val
LSE
0O0C
Astarta Holding Nv
BOV
VLOE34R
Valero Energy
USOTC
HOYFF
Huhtamaeki Oy (PK)
ASX
SCGJOA
LSE
0UK8
LSE
TV2V
Thames Ventures Vct 2
LSE
SV55
Tsb Bank 26
ASX
EZL
Euroz Hartleys
BOV
VALEF12
VALEF12 Ex:107,99
TSXV
NTY
92 Resources
LATK
DIVERUSDT
DivergenceProtocol
ASX
TECH
Global X Management AUS
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados